CAS: 87226-41-3 - (-)-Etodolac
Formula:C17H21NO3
InChI:InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)/t17-/m1/s1
InChI key:InChIKey=NNYBQONXHNTVIJ-QGZVFWFLSA-N
SMILES:O=C(O)CC1(OCCC=2C=3C=CC=C(C3NC21)CC)CC
- Synonyms:
- (1R)-1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid
- (-)-Etodolic acid
- R-Etodolac
- Pyrano[3,4-b]indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-, (1R)-
- Pyrano[3,4-b]indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-, (R)-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
(R)-Etodolac REF: 4Z-E-056CAS: 87226-41-3 | - - - | To inquire | Tue 14 Jan 25 | |
(R)-(-)-Etodolac REF: TR-E933090CAS: 87226-41-3 | - - - | 279.00 €~1,852.00 € | Wed 15 Jan 25 | |
(R)-Etodolac REF: 54-BICR251CAS: 87226-41-3 | - - - | - - - | Discontinued product | |
(R)-(-)-Etodolac REF: 3D-FE23193CAS: 87226-41-3 | Min. 95% | - - - | Discontinued product |
Ref: 4Z-E-056
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
(R)-(-)-Etodolac
Controlled ProductCAS:87226-41-3
Applications The R-enantiomer of Etodolac (E933090). Anti-inflammatory; analgesic. References Boxenbaum, H., et al.: J. Pharmacokin. …
Formula:
C17H21NO3
Color and Shape:
Neat
Molecular weight:
287.354
Ref: TR-E933090
5mg | 279.00 € | ||
50mg | 1,852.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
Ref: 54-BICR251
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information |
(R)-(-)-Etodolac
CAS:87226-41-3
Etodolac is a non-steroidal anti-inflammatory drug (NSAID) that inhibits prostaglandin synthesis. It also has a …
Formula:
C17H21NO3
Purity:
Min. 95%
Molecular weight:
287.35 g/mol
Ref: 3D-FE23193
1mg | Discontinued | Request information | |
2mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information |